NIH-funded research Fellowship grant

How stress affects heart cell function and communication

Official title: Stress-induced loss of BIV-spectrin regulates cardiac fibroblast function and long-range communication

Funded at Ohio State University · NIH-11006248 · Data updated 2026-11-12

This study is looking at how stress affects a protein that helps heart cells heal after a heart attack, with the goal of finding new ways to improve heart recovery and prevent problems like irregular heartbeats.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startAugust 1, 2023
Project endJuly 31, 2026
Funding year2024
Award (this year)$44,224
NIH project number5F31HL170749-02
Project IDNIH-11006248 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced a myocardial infarction or are at risk for heart disease.

Less likely to help

Patients with non-cardiac conditions or those who have not experienced heart-related issues may not benefit from this research.

What this research studies

This research investigates how stress-induced changes in a specific protein, βIV-spectrin, impact the function of cardiac fibroblasts, which are crucial for heart healing after injury. The study focuses on understanding the mechanisms that lead to the activation of these cells following a heart attack, including their proliferation and the signals they send to other heart cells. By examining the role of calcium-dependent proteins in this process, the research aims to uncover new insights into how heart tissue heals and how improper healing can lead to complications like arrhythmias. Patients may benefit from a better understanding of heart recovery processes and potential new treatments.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for heart attack recovery and reduced risk of complications such as arrhythmias.

How similar studies have gone: Previous research has shown promising results in understanding cardiac fibroblast behavior, but this specific approach focusing on βIV-spectrin is relatively novel.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Shaheen, Rebecca J. — Ohio State University
  • Study coordinator: Shaheen, Rebecca J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.